Scotland · NHS Scotland MSAN
Rifampicin and Isoniazid (Rifinah®) 300mg/150mg tablets
MSAN(2024)61 · Level 2 · issued 30 Oct 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Sanofi are out of stock of Rifinah® 300mg/150mg tablets. Resupply is expected in mid | Out of stock | — |
| 2. Rifinah® 150mg/100mg tablets remain available but are unable to support any increase in | Available | — |
| 3. Rifampicin 300mg capsules and isoniazid 100mg tablets remain available and can support a full | Available | — |
| 4. Isoniazid 50mg tablets remain available and can support a partial uplift in demand. | Available — partial uplift only | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:61
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
669e617aae5907b1151385bbd7b1cd4ddf7e5d28cf13f12cd68a64affe4916casha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-61.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.